To decipher the opposite effects of PLA2R1 in LNCaP and PC-3 cells together with those described in the breast cancer cell line MDA-MB-453, we validated our transfection method and experimental procedures by transfecting MDA-MB-453 cells to overexpress PLA2R1. This evidence concerns the gene PLA2R1 and breast carcinoma.